greeksoup/ stock research
Stock research / United States / BVS / Planned sales

Bioventus Inc. planned insider sales

In the last twelve months insiders at Bioventus Inc. filed 3 Form 144 notices of planned sales, 49,000 shares worth $381,419 at the time of filing, from 2 sellers. The latest, filed 11 March 2026: McMurry-Heath Michelle (director), 12,000 shares worth $105,720, planned for around 11 March 2026 through Fidelity Brokerage Services LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
11 March 2026McMurry-Heath MichelleDirector12,000$105,72011 March 202612,000 shares from 11 March 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
4 December 2025Nohra Guy PDirector10,000$75,6584 December 202510,000 shares from 4 December 2025Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
7 November 2025McMurry-Heath MichelleDirector27,000$200,0417 November 202517,701 shares from 7 November 2025Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?